Johnson & Johnson to Acquire Firefly Bio for $1B

Breaking News

Sartorius Opens New Competence Center in Freiburg, Germany

Reaffirms its strategic focus on manufacturing essential components such as cytokines and growth factors used in novel cell and gene therapies.

SPONSOR

DNA-to-IND in as little as 6 months

Our enhanced offering enables mAb programs to achieve IND readiness in as little as 6 months, with tox‑grade DS available in ~2 months.

Breaking News
Collaborations & Alliances

AmMax Bio, Lonza Enter Non-Exclusive Licensing Agreement for AMB-104

AMB-104 provides a unique solution to address venetoclax/azacitidine resistance in acute myeloid leukemia (AML).

Breaking News
Collaborations & Alliances

Pfizer, Innovent Strike $10.5 Billion Oncology Deal to Develop 12 Cancer Medicines

The partnership includes licensing, co-development, and co-commercialization opportunities across a diverse portfolio of antibody-drug conjugates.

SPONSOR

The Benefits of Transparent Pricing

How to compare CMO proposals and know what your true costs will be.

Breaking News
Collaborations & Alliances

Haisco, Lilly Strike Drug Development Deal

Licensing and research collaboration covers up to five programs with potential milestone payments nearing $3 billion.

SPONSOR

Regulatory expertise

With expertise in traditional and advanced therapies, Cardinal Health Regulatory Sciences will collaborate throughout the product lifecycle to help achieve your regulatory goals. Learn more.